High flow nasal cannula oxygen and non-invasive mechanical ventilation in management of COVID-19 patients with acute respiratory failure: a retrospective observational study

Springer Science and Business Media LLC - 2021
Amr Shoukri1
1Department of Chest Diseases, Faculty of Medicine, Ain Shams University, 43 ElMahrouky street, Heliopolis, Cairo, 11341, Egypt

Tóm tắt

Abstract Background High flow nasal cannula oxygen (HFNCO) is a relatively new technique used to deliver oxygen in respiratory failure patients. This retrospective study is aiming to assess the role and benefits of using HFNCO compared to non-invasive ventilation (NIV) in management of patients with acute hypoxemic respiratory failure associated with coronavirus disease 2019 (COVID-19). Results A retrospective analysis of the files of 63 patients with COVID-19 and acute hypoxemic respiratory failure admitted to the intensive care unit (ICU), 37 patients received HFNCO as initial therapy, and 26 patients were primarily treated with NIV. There was no significant difference between the 2 groups in terms of baseline characteristics, laboratory tests, arterial blood gases, PaO2/FiO2 values, and vital signs. Re-assessment after 24 h of starting treatment with either HFNCO or NIV showed significant improvement (P<0.01) in the respiratory rate, heart rate, and oxygenation parameters. The magnitude of improvement of the vital signs and oxygenation was not significantly different between patients using HFNCO or NIV. Success rate of HFNCO was 86.4%, endotracheal intubation with invasive mechanical ventilation was required in 10.81% of patients, and mortality rate was 2.7%. Success rate of NIV was 84.6%, endotracheal intubation rate was 11.53%, and mortality rate was 3.8%. No significant difference (P>0.05) between the 2 groups as regards the duration of treatment, rate of endotracheal intubation with invasive mechanical ventilation, and mortality rate. Conclusion High flow nasal cannula oxygen (HFNCO) is effective in the management of acute hypoxemic respiratory failure associated with COVID-19. Its efficacy is similar to NIV, with no difference in the duration of treatment, endotracheal intubation rate, or mortality rate.

Từ khóa


Tài liệu tham khảo

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032

Bein B, Bachmann M, Huggett S, Wegermann P (2020) SARS CoV-2/COVID-19: evidence-based recommendation on diagnosis and therapy. Anasthesiol Intensivmed Notfallmed Schmerzther 55(4):257–265

Nishimura M (2015) High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 3(1):15. https://doi.org/10.1186/s40560-015-0084-5

Respiratory & Critical Care Medicine Group of Chinese Thoracic Society (2019) Expert consensus of high flow nasal cannula oxygen therapy on clinical application regularity. Zhonghua Jie He He Hu Xi Za Zhi. 42:83–91

Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ et al (2017) An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 195(9):1253–1263. https://doi.org/10.1164/rccm.201703-0548ST

Keenan SP, Sinuff T, Burns KE, Muscedere J, Kutsogiannis J, Mehta S et al (2011) Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting. CMAJ. 183(3):E195–E214. https://doi.org/10.1503/cmaj.100071

Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S et al (2017) Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 50(2):1602426. https://doi.org/10.1183/13993003.02426-2016

Roca O, Riera J, Torres F, Masclans JR (2010) High-flow oxygen therapy in acute respiratory failure. Respir Care 55(4):408–413

Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, Ricard JD (2011) Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 37(11):1780–1786. https://doi.org/10.1007/s00134-011-2354-6

Duan J, Chen B, Liu X, Shu W, Zhao W, Li J, Li Y, Hong Y, Pan L, Wang K (2020) Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: A multicenter observational study. Am J Emerg Med. https://doi.org/10.1016/j.ajem.2020.07.071

Monro-Somerville T, Sim M, Ruddy J, Vilas M, Gillies MA (2016) The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med. 45:e449–e456

Maitra S, Som A, Bhattacharjee S, Arora MK, Baidya DK (2016) Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: a meta-analysis and systematic review. J Crit Care. 35:138–144. https://doi.org/10.1016/j.jcrc.2016.05.013

Zhao H, Wang H, Sun F, Lyu S, An Y (2017) High-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy but not to noninvasive mechanical ventilation on intubation rate: a systematic review and meta-analysis. Crit Care 21:184

Duan J, Han X, Bai L, Zhou L, Huang S (2017) Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 43(2):192–199. https://doi.org/10.1007/s00134-016-4601-3

Kang BJ, Koh Y, Lim CM, Baek S, Han M, Seo H-S et al (2015) Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 41(4):623–632. https://doi.org/10.1007/s00134-015-3693-5

Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, Coudroy R, Petitpas F, Robert R, Thille AW, Girault C (2015) Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care. 60(2):170–178. https://doi.org/10.4187/respcare.03075

Lindenauer PK, Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Hill NS (2014) Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med. 174(12):1982–1993. https://doi.org/10.1001/jamainternmed.2014.5430

Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JCM, Brochard L, Robert R (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 372(23):2185–2196. https://doi.org/10.1056/NEJMoa1503326

Hui DS, Chow BK, Lo T, Tsang OT, Ko FW, Susanna S (2019) Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 53(4):1802339

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả